ResearcherWuhan UniversityActive in the last 2 years
Zhiliang Wang
Matched on ORCID iD 0009-0004-9867-2055; OpenAlex author ID A5102570655. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 4
- Low-dose Simvastatin protects pancreatic cancer cells by promoting mitochondrial autophagy through TFEB. Co-author DOI 10.1007/s13402-026-01164-y↗
- Prognostic and immune microenvironment analysis of cuproptosis-related lncRNAs in human pancreatic cancer. Last author DOI 10.1016/j.compbiomed.2025.111004↗
- PITX2 functions as a transcription factor for GPX4 and protects pancreatic cancer cells from ferroptosis. Co-author DOI 10.1016/j.yexcr.2024.114074↗
- IL15RA-STAT3-GPX4/ACSL3 signaling leads to ferroptosis resistance in pancreatic cancer. First author DOI 10.3724/abbs.2024153↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaowu Xu · 3 shared papers, 2024–2026 · strength 0.64
- Paper Low-dose Simvastatin protects pancreatic cancer cells by promoting mitochondrial autophagy through TFEB. DOI 10.1007/s13402-026-01164-y↗
- Paper IL15RA-STAT3-GPX4/ACSL3 signaling leads to ferroptosis resistance in pancreatic cancer. DOI 10.3724/abbs.2024153↗
- Paper PITX2 functions as a transcription factor for GPX4 and protects pancreatic cancer cells from ferroptosis. DOI 10.1016/j.yexcr.2024.114074↗
- Zhiyong Yang · 1 shared paper, 2025 · strength 0.25
- Hong Duo · 1 shared paper, 2025 · strength 0.25
- Qifa Ye · 1 shared paper, 2025 · strength 0.25
- Xuemin Chen · 1 shared paper, 2026 · strength 0.24
- Di Wu · 1 shared paper, 2024 · strength 0.20
- Xuemin Chen · 1 shared paper, 2024 · strength 0.20
- Yue Zhang · 1 shared paper, 2024 · strength 0.20
- Xianjun Yu · 1 shared paper, 2024 · strength 0.20
- Yi Qin · 1 shared paper, 2024 · strength 0.20
- Xuemin Chen · 1 shared paper, 2024 · strength 0.20
- Yue Zhang · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.